President Donald Trump signed an executive order on Saturday aimed at accelerating research into psychedelic drugs as potential treatments for mental health conditions, particularly targeting veterans with PTSD.

According to Fox News, the executive order came about following a text exchange between Trump and podcast host Joe Rogan, who reportedly influenced the president's decision to fast-track federal review of psychedelics research.

The order represents the latest development in the Trump administration's evolving approach to drug policy. In December 2024, Trump moved to reclassify marijuana as a less dangerous controlled substance, signaling a shift toward less restrictive federal drug policies.

The executive order specifically focuses on expediting research into psychedelics as treatments for mental illness, with particular attention to helping veterans suffering from post-traumatic stress disorder. The administration appears to be prioritizing alternative treatment options for conditions that have proven difficult to treat with traditional therapies.

The signing follows growing scientific interest in psychedelic compounds such as psilocybin and MDMA, which have shown promise in clinical trials for treating depression, PTSD, and other mental health conditions. Several states and localities have already moved to decriminalize or allow research into these substances.